357 filings
Page 16 of 18
SC 13G/A
Point72 Asset Management, L.P.
16 Feb 16
Trillium Therapeutics Inc.
12:00am
SC 13G/A
Merlin BioMed Private Equity Advisors, L.L.C.
12 Feb 16
Trillium Therapeutics Inc.
12:00am
SC 13G/A
Opaleye Management Inc.
12 Feb 16
Trillium Therapeutics Inc.
12:00am
SC 13G
BEN
Franklin Resources, Inc.
10 Feb 16
Trillium Therapeutics Inc.
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
5 Feb 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
3 Feb 16
Current report (foreign)
12:00am
SC 13G/A
Stebbins James Henry DeGraff
29 Jan 16
Beneficial ownership report (amended)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
27 Jan 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
3 Dec 15
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
12 Nov 15
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
30 Sep 15
Trillium Therapeutics Provides Update on CD47 Program
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
12 Aug 15
Interim Condensed Consolidated Financial Statements
12:00am
EFFECT
TRIL
Trillium Therapeutics Inc.
5 Jun 15
Notice of effectiveness
12:00am
F-10/A
TRIL
Trillium Therapeutics Inc.
5 Jun 15
Registration of securities (Canada) (amended)
12:00am
F-10
TRIL
Trillium Therapeutics Inc.
29 May 15
Registration of securities (Canada)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
29 May 15
Current report (foreign)
12:00am
F-X
TRIL
Trillium Therapeutics Inc.
29 May 15
Appointment of agent for service of process by issuers registering securities
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
13 May 15
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
30 Apr 15
Annual General Meeting of Shareholders
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
29 Apr 15
Form 51-102F3 Material Change Report
12:00am